Ascendis Pharma A/S News

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Moomoo NewsDec 23 09:31 ET

Evercore Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $220

Moomoo NewsDec 20 13:31 ET

Jefferies Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $194

Moomoo NewsDec 18 10:31 ET

A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $167 to $211

Moomoo NewsDec 17 08:00 ET

Ascendis Pharma (ASND) Gets a Buy From Stifel Nicolaus

TipRanksDec 16 21:06 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Moomoo NewsDec 9 09:31 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Moomoo NewsDec 2 08:32 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Moomoo NewsNov 25 10:33 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Moomoo NewsNov 19 03:43 ET

A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $153 to $207

Moomoo NewsNov 16 08:00 ET

Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald

Dow JonesNov 15 09:54 ET

Oppenheimer Adjusts Ascendis Pharma A/S Price Target to $180 From $190, Maintains Outperform Rating

MT NewswiresNov 15 09:14 ET

Ascendis Pharma Is Maintained at Buy by Stifel

Dow JonesNov 15 08:33 ET

Ascendis Pharma Analyst Ratings

BenzingaNov 15 08:23 ET

Wedbush Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $181

Moomoo NewsNov 15 07:31 ET

TD Cowen Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Cuts Target Price to $153

Moomoo NewsNov 15 07:31 ET

Wells Fargo Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $289

Moomoo NewsNov 15 05:34 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Moomoo NewsNov 11 08:37 ET

A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $167 to $289

Moomoo NewsNov 5 08:07 ET

Ascendis Pharma Analyst Ratings

BenzingaNov 4 08:43 ET